AI CAPITAL INTELLIGENCE

Indurex · Undisclosed round · EUR 7,000,000 · 2026-10-22

Financing facts, at a glance

Indurex: financing disclosed on 2026-10-22, Undisclosed round, EUR 7,000,000. Named investors: Contrarian Ventures, Axeleo Capital, Curiosity. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.

Original source 1 · Original source 2

Indurex is recorded in the Enterprise AI / Cybersecurity & risk segment. The disclosed financing is Undisclosed round, with an amount of EUR 7,000,000. Named investors include Contrarian Ventures, Axeleo Capital, Curiosity.

Disclosed company name
Indurex
Disclosure date
2026-10-22
Round
Undisclosed round
Financing amount
EUR 7,000,000
Market coverage
Outside China
Sector
Enterprise AI / Cybersecurity & risk
Product form
Enterprise software

Disclosed investors

Contrarian Ventures, Axeleo Capital, Curiosity

Sources for this round

  1. 阿姆斯特丹的Indurex融资700万欧元,以加强网络物理系统的网络安全与安全

    www.eu-startups.com · Original publication date not recorded

  2. Indurex Raises €7M in Funding

    thesaasnews.com · Original publication date not recorded

Collection batch . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.

Company funding history

Explore this sector

All funding records

Citation and coverage

Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market.

Wavesight AI|Indurex · Undisclosed round · EUR 7,000,000 · 2026-10-22。Indurex: financing disclosed on 2026-10-22, Undisclosed round, EUR 7,000,000. Named investors: Contrarian Ventures, Axeleo Capital, Curiosity. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment. Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market. https://www.zkdlj.vip/en/funding/FI-01bd383540602152/#conclusion-overview

Link to conclusion